Results 91 to 100 of about 184,390 (149)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis. [PDF]

Medicine (Baltimore), 2021
Yuan X, Zhang AZ, Ren YL, Wang XL, Jiang CH, Yang L, Liu CX, Liang WH, Pang LJ, Gu WY, Li F, Hu JM.   +11 more
europepmc   +1 more source

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma. [PDF]

Int J Mol Sci, 2023
Ge F, Wang Y, Sharma A, Yang Y, Liu H, Essler M, Jaehde U, Schmidt-Wolf IGH.   +7 more
europepmc   +1 more source

Cytokine-induced memory-like natural killer cells in systemic lupus erythematosus patients

Advances in Rheumatology
Background Natural killer (NK) cell abnormalities may contribute to the pathogenesis of systemic lupus erythematosus (SLE). Interleukin (IL)-15, an immunoregulatory cytokine crucial for NK survival, is overexpressed in SLE patients.
Chien-Ya Hsu, Yen-Chang Lee, Hsiu-Shan Hsiao, Pei-Tzu Lee, Ji-Yih Chen, Syh-Jae Lin   +5 more
doaj   +1 more source

Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials. [PDF]

Cancers (Basel), 2021
Zhang Y, Sharma A, Weiher H, Schmid M, Kristiansen G, Schmidt-Wolf IGH.   +5 more
europepmc   +1 more source

Effects of interleukin-2 concentration and administration method on proliferation and function of cytokine-induced killer cells. [PDF]

Transl Cancer Res, 2021
Liu Y, Li J, Zhao L, Zhu J, Liu S, Wang H, Zhang Y.   +6 more
europepmc   +1 more source

MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells. [PDF]

Stem Cells Int, 2023
Dong M, Zhang G, Meng J, Liu B, Jiang D, Liu F.   +5 more
europepmc   +1 more source

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer. [PDF]

Front Oncol, 2022
Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q.   +15 more
europepmc   +1 more source

Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. [PDF]

J Immunother Cancer, 2021
Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, Chieregato K, Mozzo V, Perbellini O, Tisi MC, Trentin L, Visco C, Ruggeri M, Sommaggio R, Rosato A.   +14 more
europepmc   +1 more source

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation. [PDF]

Front Immunol, 2021
Wu X, Sharma A, Oldenburg J, Weiher H, Essler M, Skowasch D, Schmidt-Wolf IGH.   +6 more
europepmc   +1 more source

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies. [PDF]

J Healthc Eng, 2021
Yang Y, Wang RQ, Zhong YM, Meng MY, Zhao YY, Yang LR, Li L, Hou ZL.   +7 more
europepmc   +1 more source